Adefovir dipivoxil for wait‐listed and post–liver transplantation patients with lamivudine‐resistant hepatitis B: Final long‐term results
暂无分享,去创建一个
E. Schiff | J. Villeneuve | D. Samuel | N. Terrault | P. Neuhaus | H. Tillmann | S. Zeuzem | S. Chuck | K. Borroto-Esoda | S. Arterburn | S. Hadziyannis | M. Colombo | C. Brosgart | Ching‐lung Lai
[1] S. Fan,et al. Liver transplantation for chronic hepatitis B with lamivudine‐resistant YMDD mutant using add‐on adefovir dipivoxil plus lamivudine , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] F. Azorin,et al. Adefovir Dipivoxil Therapy in Liver Transplant Recipients With Lamivudine-Resistant Hepatitis B Virus , 2005 .
[3] H. Marusawa,et al. Prevention of hepatitis B virus recurrence after living donor liver transplantation. , 2004, Transplantation proceedings.
[4] C. Wai,et al. Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant. , 2004, Transplantation proceedings.
[5] N. Terrault,et al. Antiviral therapy in patients with chronic hepatitis B and cirrhosis. , 2004, Gastroenterology clinics of North America.
[6] Wen-Yuan Guo,et al. Prevention of hepatitis B virus reinfection after orthotopic liver transplantation. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.
[7] S. Ferretti,et al. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation. , 2004, Transplantation proceedings.
[8] M. Wulfsohn,et al. Adefovir dipivoxil therapy for lamivudine‐resistant hepatitis B in pre– and post–liver transplantation patients , 2003, Hepatology.
[9] F. Zoulim. Treatment of pre‐ and post‐liver transplantation HBV infection: Should we aim at combination therapy? , 2003, Hepatology.
[10] F. Villamil. Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection. , 2003, Journal of hepatology.
[11] D. Samuel,et al. HBV DNA persistence 10 years after liver transplantation despite successful anti‐HBS passive immunoprophylaxis , 2003, Hepatology.
[12] F. Zoulim. Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation? , 2003, Journal of hepatology.
[13] M. Buti,et al. A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation. , 2003, Journal of hepatology.
[14] M. Brunetto,et al. Diagnosis and monitoring of hepatitis virus infection in liver transplant patients. , 2003, Transplantation proceedings.
[15] M. Rizzetto,et al. Prophylaxis of hepatitis B virus infection before liver transplantation, 1990-2001: a single-center experience. , 2003, Transplantation proceedings.
[16] F. Mosca,et al. Impact of antiviral treatment on recurrence of hepatitis B virus infection and disease. , 2003, Transplantation proceedings.
[17] M. Wulfsohn,et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. , 2003, The New England journal of medicine.
[18] C. Gibbs,et al. Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks , 2002, Hepatology.
[19] R. Fontana,et al. Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B , 2002, Liver transplantation.
[20] T. Berg,et al. Occurrence and clinical outcome of lamivudine‐resistant hepatitis B infection after liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[21] N. Terrault,et al. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort , 2001, Hepatology.
[22] F. Negro,et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. , 2001, Journal of hepatology.
[23] B. Portmann,et al. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. , 2001, Journal of hepatology.
[24] E. Schiff,et al. A multicenter United States—Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B , 2001, Hepatology.
[25] A. Burroughs,et al. LAMIVUDINE WITHOUT HBIg FOR PREVENTION OF GRAFT REINFECTION BY HEPATITIS B: LONG-TERM FOLLOW-UP , 2000, Transplantation.
[26] A. Humar,et al. Lamivudine for hepatitis B in liver transplantation: a single-center experience. , 2000, Transplantation.
[27] J. Villeneuve,et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B , 2000, Hepatology.
[28] M. Manns,et al. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under hbig immunoglobulin after liver transplantation , 1999, Hepatology.
[29] S. Cheung,et al. Liver Transplantation in Asian Patients With Chronic Hepatitis B Using Lamivudine Prophylaxis , 1999, Annals of surgery.
[30] E. Schiff,et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation , 1999, Hepatology.
[31] J. Markmann,et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin , 1998, Hepatology.
[32] E. Schiff,et al. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. , 1998, Transplantation.
[33] J. Roberts,et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin , 1996, Hepatology.
[34] A. Burroughs,et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis , 1996, The Lancet.
[35] M. Manns,et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis , 1996, Hepatology.
[36] T. Pruett,et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. , 1996, Transplantation.
[37] G. Alexander,et al. Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.
[38] D. Samuel,et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients , 1991, The Lancet.
[39] R. Pichlmayr,et al. Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. , 1987, Transplantation proceedings.
[40] S. Cotler,et al. Management of hepatitis B in liver transplant patients. , 2005, Journal of clinical gastroenterology.
[41] J. L. Lucena de la Poza,et al. Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus. , 2005, Transplantation proceedings.
[42] Yao Guang. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B in China , 2005 .
[43] D. Samuel. Management of hepatitis B in liver transplantation patients. , 2004, Seminars in liver disease.
[44] E. Albéniz Arbizu,et al. Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft. , 2003, Transplantation proceedings.
[45] S. Davies,et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. , 1992, Journal of hepatology.